COVID-19 tracker: Moderna to take over vaccine marketing duties in Japannews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
COVID-19 tracker: Pfizer, with new vaccine R&D chief inbound, petitions FDA for third dose in young kidsnews2022-04-13T18:42:33+00:00April 13th, 2022|Fierce Pharma|
AbbVie president Severino departs to help pilot Flagship Pioneeringnews2022-04-13T15:26:37+00:00April 13th, 2022|Fierce Pharma|
Amgen parts ways with part of Ventura County headquarters campus: reportnews2022-04-13T14:44:57+00:00April 13th, 2022|Fierce Pharma|
J&J, 2-stepping through talc litigation, faces fresh claims it hid worker’s asbestos exposurenews2022-04-13T14:23:38+00:00April 13th, 2022|Fierce Pharma|
J&J, Roche partner Halozyme buys Antares Pharma for $1B, beefing up drug delivery offeringsnews2022-04-13T13:53:20+00:00April 13th, 2022|Fierce Pharma|
With recent notices of ‘deficiencies,’ the FDA may be ‘raising the regulatory bar’: analystnews2022-04-13T13:35:28+00:00April 13th, 2022|Fierce Pharma|
The mysterious case of Viatris and the missing insulin label deepensnews2022-04-13T12:46:03+00:00April 13th, 2022|Fierce Pharma|
Bristol Myers Squibb’s aging Orencia finds new life with rheumatologists as they shun newer JAK drugs from Pfizer, AbbVie: reportnews2022-04-13T06:39:40+00:00April 13th, 2022|Fierce Pharma|
FDA slaps another hold on Ocugen, Bharat’s COVID vaccine after WHO flags manufacturing problemsnews2022-04-12T20:11:08+00:00April 12th, 2022|Fierce Pharma|
